Understanding why clinicians should care about danger-associated molecular patterns

Intensive Care Med. 2016 Apr;42(4):611-614. doi: 10.1007/s00134-015-4198-y. Epub 2016 Feb 24.

Authors

Karim Asehnoune¹, Richard S Hotchkiss², Guillaume Monneret³

Affiliations

¹ Department of Anesthesiology and Critical Care Medicine, Hôtel Dieu, Centre hospitalier universitaire (CHU) de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France. Karim.Asehnoune@chu-nantes.fr.
² Departments of Anesthesiology, Medicine, and Surgery, Washington University School of Medicine, St Louis, MO, USA.
³ Immunology Department, Hôpital Edouard Herriot , Hospices Civils de Lyon, 69003, Lyon, France.

PMID: 26912314
DOI: 10.1007/s00134-015-4198-y

No abstract available

Publication types

Comment
Editorial